Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. (May 2019)
- Record Type:
- Journal Article
- Title:
- Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. (May 2019)
- Main Title:
- Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk
- Authors:
- Loi, Mauro
Magallon-Baro, Alba
Suker, Mustafa
van Eijck, Casper
Sharma, Aman
Hoogeman, Mischa
Nuyttens, Joost - Abstract:
- Highlights: Considerable trade-off target coverage/OAR sparing in SBRT for pancreatic cancer. Daily change in OAR position may increase uncertainty in dose delivery and toxicity. Daily dose to OARs during SBRT was evaluated using a CyberKnife with integrated CT. Median increase was statistically significant for V35 in all critical structures. Daily imaging may allow to implement strategies to reduce OAR overirradiation. Abstract: Background and purpose: Interfraction shape and position variations of organs at risk (OARs) may increase uncertainty in dose delivery during stereotactic body radiotherapy (SBRT), potentially leading to overirradiation or concessions in planned tumor dose and/or coverage to prevent clinical constraints violation. The aim of our study was to quantitatively analyze the impact of anatomical interfraction variations on dose to OARs in pancreatic cancer (PC) treated by SBRT using a CyberKnife with integrated CT-on-rails. Materials and methods: Thirty-five PC patients treated with SBRT (40 Gy/5 fractions) underwent a CT-scan in treatment position before each of the first three fractions using the CT-on-rails system. OARs (stomach, duodenum, bowel) were manually delineated and concatenated to one structure (Gastro-Intestinal Organ, GIO). To overlay the planned dose distribution, fiducial-based alignment of the fraction CT with the planning CT was performed. Planned DVH parameters of the OAR were compared to the parameters calculated in the fractions CTs.Highlights: Considerable trade-off target coverage/OAR sparing in SBRT for pancreatic cancer. Daily change in OAR position may increase uncertainty in dose delivery and toxicity. Daily dose to OARs during SBRT was evaluated using a CyberKnife with integrated CT. Median increase was statistically significant for V35 in all critical structures. Daily imaging may allow to implement strategies to reduce OAR overirradiation. Abstract: Background and purpose: Interfraction shape and position variations of organs at risk (OARs) may increase uncertainty in dose delivery during stereotactic body radiotherapy (SBRT), potentially leading to overirradiation or concessions in planned tumor dose and/or coverage to prevent clinical constraints violation. The aim of our study was to quantitatively analyze the impact of anatomical interfraction variations on dose to OARs in pancreatic cancer (PC) treated by SBRT using a CyberKnife with integrated CT-on-rails. Materials and methods: Thirty-five PC patients treated with SBRT (40 Gy/5 fractions) underwent a CT-scan in treatment position before each of the first three fractions using the CT-on-rails system. OARs (stomach, duodenum, bowel) were manually delineated and concatenated to one structure (Gastro-Intestinal Organ, GIO). To overlay the planned dose distribution, fiducial-based alignment of the fraction CT with the planning CT was performed. Planned DVH parameters of the OAR were compared to the parameters calculated in the fractions CTs. Results: Compared to the treatment plan, the median V35, D2, D5, D10 and Dmax of the fraction CTs in the GIO was increased by 1.0 (IQR: 0.2–2.6), 4.4% (0.4–10.8), 2.3% (0.2–7.5), 3.3% (−0.4 to 7.1), and 12.0% (5.0–18.9) respectively. Median increase was statistically significant for all parameters in GIO and for V35 in all critical structures at Wilcoxon test. Conclusions: Anatomical interfraction variations increase OAR dose during SBRT for pancreatic cancer daily imaging using integrated CT/CyberKnife may allow to implement strategies to reduce the risk of OAR overirradiation during pancreatic SBRT. … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 134(2019)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 134(2019)
- Issue Display:
- Volume 134, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 134
- Issue:
- 2019
- Issue Sort Value:
- 2019-0134-2019-0000
- Page Start:
- 67
- Page End:
- 73
- Publication Date:
- 2019-05
- Subjects:
- Interfraction variation -- Organ motion -- Dosimetry -- Pancreatic cancer -- SBRT
Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2019.01.020 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9982.xml